MDs on Botox [botulinum toxin A] Utility (MOBILITY).
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Benign prostatic hyperplasia; Migraine; Overactive bladder
- Focus Therapeutic Use
- Acronyms MOBILITY
- Sponsors Allergan
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2012 Planned End Date changed from 1 Dec 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.